Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome

Open accessCopyright infoDownload PDFeLife Lens

Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome

Affiliation details

DOI: http://dx.doi.org/10.7554/eLife.01305Published December 24, 2013 Cite as eLife 2013;2:e01305

Abstract

Mutations in CHD7 are the major cause of CHARGE syndrome, an autosomal dominant disorder with an estimated prevalence of 1/15,000. We have little understanding of the disruptions in the developmental programme that underpin brain defects associated with this syndrome. Using mouse models, we show that Chd7 haploinsufficiency results in reduced Fgf8 expression in the isthmus organiser (IsO), an embryonic signalling centre that directs early cerebellar development. Consistent with this observation, Chd7 and Fgf8 loss-of-function alleles interact during cerebellar development. CHD7 associates with Otx2 and Gbx2 regulatory elements and altered expression of these homeobox genes implicates CHD7 in the maintenance of cerebellar identity during embryogenesis. Finally, we report cerebellar vermis hypoplasia in 35% of CHARGE syndrome patients with a proven CHD7 mutation. These observations provide key insights into the molecular aetiology of cerebellar defects in CHARGE syndrome and link reduced FGF signalling to cerebellar vermis hypoplasia in a human syndrome.

DOI: http://dx.doi.org/10.7554/eLife.01305.001

eLife digest

CHARGE syndrome is a rare genetic condition that causes various developmental abnormalities, including heart defects, deafness and neurological defects. In most cases, it is caused by mutations in a human gene called CHD7. CHD7 is known to control the expression of other genes during embryonic development, but the molecular mechanisms by which mutations in CHD7 lead to the neural defects found in CHARGE syndrome are unclear.

During embryonic development, the neural tube—the precursor to the nervous system—is divided into segments, which give rise to different neural structures. The r1 segment, for example, forms the cerebellum, and the secretion of a protein called FGF8 (short for fibroblast growth factor 8) by a nearby structure called the isthmus organiser has an important role in this process. Since a reduction in FGF8 causes defects similar to those found in CHARGE syndrome, Yu et al. decided to investigate if the FGF signalling pathway was involved in this syndrome.

Mice should have two working copies of the Chd7 gene, and mice that lack one of these suffer from symptoms similar to those of humans with CHARGE syndrome. Yu et al. examined the embryos of these mice and found that the isthmus organiser produced less FGF8. Embryos with no working copies of the gene completely lost the r1 segment. The loss of this segment appeared to be caused by changes in the expression of homeobox genes (the genes that determine the identity of brain segments).

Embryos that did not have any working copies of the Chd7 gene died early in development, which made further studies impossible. However, embryos that had one working copy of the Chd7 gene survived, and Yu et al. took advantage of this to study the effects of reduced FGF8 expression on these mice. These experiments showed that mice with just one working copy of the Fgf8 gene and one working copy of the Chd7 gene had a small cerebellar vermis. This part of the cerebellum is known to be very sensitive to changes in FGF8 signalling. Yu et al. then used an MRI scanner to look at the cerebellar vermis in patients with CHARGE syndrome, and found that more than half of the patients had abnormal cerebella.

In addition to confirming that studies on mouse embryos can provide insights into human disease, the work of Yu et al. add defects in the cerebellar vermis to the list of developmental abnormalities associated with CHARGE syndrome. The next step will be to test if any mutations in the human FGF8 gene can contribute to cerebellar defects in CHARGE syndrome, and to investigate if any other developmental defects in CHARGE syndrome are associated with abnormal FGF8 levels.

DOI: http://dx.doi.org/10.7554/eLife.01305.002

Main text

Introduction

The segmental organisation of the embryonic neural tube is imparted by the action of homeobox genes that show defined expression patterns along its anterior-posterior axis, in combination with growth factors secreted from distinct organising centres (Kiecker and Lumsden, 2012). The cerebellum is derived from dorsal rhombomere 1 (r1), the anterior-most segment of the embryonic hindbrain. The survival and patterning of r1 is controlled by Fibroblast Growth Factor 8 (FGF8), secreted from the isthmus organiser (IsO), an organising centre located at the boundary between the embryonic midbrain (mesencephalon, mes) and r1 (reviewed by Nakamura et al., 2005; Martinez et al., 2013). The IsO forms at the expression boundary of two homeobox genes: Otx2 (Orthodenticle Homeobox 2) in the anterior neural tube and, Gbx2 (Gastrulation Brain Homeobox 2), in the posterior neural tube. Fgf8 expression in the IsO is initiated at early (3–5) somite stages in the mouse embryo, resulting in a stable gene-regulatory network at the IsO, where (1) cross-repressive interactions between Otx2 and Gbx2 maintain the IsO, (2) Otx2 represses Fgf8 expression, thus restricting it to r1, and (3) Fgf8 and Gbx2 contribute to the maintenance of each other’s expression (reviewed by Joyner et al., 2000; Martinez et al., 2013).

Studies in the mouse embryo have shown that the level of FGF gene expression and signalling from the IsO has to be tightly controlled to ensure normal cerebellar development. Altered FGF signalling in the mes/r1 region preferentially affects the development of the medial cerebellum, the vermis (Xu et al., 2000; Trokovic et al., 2003; Basson et al., 2008; Yu et al., 2011), which is derived from precursors in the most anterior part of r1, closest to the source of FGF8 expression (Sgaier et al., 2005). The observation that reduced FGF signalling results in hypoplasia of the cerebellar vermis in mice raises the possibility that reduced FGF signalling might underlie vermis hypoplasia in certain human conditions. However, studies in mice have also found that FGF signalling has many essential roles during development and even small reductions in Fgf8 expression during embryonic development are incompatible with postnatal survival (Meyers et al., 1998). These findings suggest that mutations causing sufficiently reduced Fgf8 expression or signalling throughout the whole embryo to result in cerebellar defects are unlikely to yield viable offspring. Rather, it seems more likely that a disruption of the mechanisms that regulate local Fgf8 expression at the IsO will be responsible for cerebellar vermis hypoplasia in humans.

CHARGE syndrome (MIM#214800) is an autosomal dominant disorder with an estimated prevalence of 1/15,000. Central nervous system defects have been reported in CHARGE (Coloboma of the eye, Heart defects, Atresia of the choanae, Retarded growth and development, Genital anomalies and Ear malformations or deafness) syndrome (Lin et al., 1990; Tellier et al., 1998; Becker et al., 2001; Issekutz et al., 2005; Sanlaville et al., 2006; Sanlaville and Verloes, 2007; Bergman et al., 2011), including reports of cerebellar defects in pre-term CHARGE fetuses (Becker et al., 2001; Sanlaville et al., 2006; Legendre et al., 2012). Depending on the clinical selection, 60–90% of the individuals suspected for CHARGE syndrome have de novo, heterozygous mutations in the CHD7 (Chromodomain helicase DNA-binding protein 7, MIM#608892) gene (Vissers et al., 2004; Bilan et al., 2012; Janssen et al., 2012). CHD7 is a member of the SNF2H-like chromatin-remodelling family and has been shown to function as a ‘transcriptional rheostat’ by maintaining appropriate levels of developmental gene expression (Schnetz et al., 2010).

A number of clinical findings led us to hypothesise that some developmental defects in CHARGE syndrome might be caused by insufficient FGF signalling levels. For example, CHARGE syndrome shows significant clinical overlap with 22q11.2 deletion and Kallmann syndromes, both of which have been linked to reduced FGF signalling (Scambler, 2010; Miraoui et al., 2013; Corsten-Janssen et al., 2013; Randall et al., 2009). We therefore set out to test the hypothesis that CHD7 is required for normal levels of Fgf8 expression during development by focusing on the embryonic IsO and cerebellar development.

Results and discussion

CHD7 regulates Fgf8 expression levels in the IsO

We previously reported that mice heterozygous for the Chd7XK403 gene-trap allele (henceforth referred to as Chd7+/− mice) phenocopy several aspects of CHARGE syndrome (Randall et al., 2009). To determine whether FGF signalling at the IsO was affected by Chd7 deletion, we first visualised the expression of Fgf8 in E9.5 embryos by in situ hybridisation. Fgf8 expression in the IsO appeared reduced in Chd7+/− embryos and was substantially downregulated in Chd7−/− embryos (Figure 1A–C). Quantitative RT-PCR analysis confirmed that Fgf8 transcripts were reduced by 20% in Chd7+/− embryos, and by 40% in Chd7−/− embryos (Figure 1D). Furthermore, Fgf8 expression was reduced by 80% in Chd7+/−;Fgf8+/− embryos, compared to 40% reduction in Chd7+/+;Fgf8+/− embryos (Figure 1D). To ask whether this synergistic genetic interaction between Chd7 and Fgf8 loss-of-function alleles translated to defects in FGF signalling, the expression of the FGF target gene Etv5 was analysed (Roehl and Nusslein-Volhard, 2001; Yu et al., 2011). Whereas Etv5 expression was clearly diminished in Chd7−/− embryos compared to wildtype controls (Figure 1E,G), it did not appear substantially reduced in Chd7+/− embryos (Figure 1F), an observation confirmed by quantitative RT-PCR (Figure 1H). However, quantitative analyses showed that Etv5 expression was reduced by 50% in Chd7+/−;Fgf8+/− embryos, compared to wildtype levels in Chd7+/− and Fgf8+/− embryos (Figure 1H). These data identified CHD7 as an upstream regulator of Fgf8 in the IsO and revealed a synergistic relationship between the Chd7 and Fgf8 genes.

Figure 1.
Download figureOpen in new tabDownload powerpointFigure 1. Reduced Fgf8 expression and FGF signalling during early cerebellar development in Chd7-deficient embryos.

(AC) In situ hybridisation for Fgf8 at E9.5 shows a Chd7 gene dosage-dependent reduction in Fgf8 expression in the mid-hindbrain isthmus organiser (IsO, arrows). Scale bar = 0.5 mm. (D) Quantification of Fgf8 transcript levels in the mes/r1 region of E9.5 embryos. (EG) Expression of the FGF-regulated gene Etv5 in E9.5 mouse embryos visualised by in situ hybridisation. (H) Quantification of Etv5 gene expression in mes/r1 tissue confirms the in situ hybridisation data and indicates a significant reduction in FGF signalling in Chd7+/−;Fgf8+/− and Chd7−/− embryos. Data represents mean ± standard error of the mean (SEM) from three individual samples for each genotype. *p<0.05, **p<0.001.

DOI: http://dx.doi.org/10.7554/eLife.01305.003

Synergistic interactions between Chd7 and Fgf8 loss-of-function alleles during development of the cerebellar vermis

Previous studies have shown that the medial cerebellum, the cerebellar vermis, is most sensitive to perturbations in FGF signalling during development (Broccoli et al., 1999; Xu et al., 2000; Trokovic et al., 2003; Basson et al., 2008; Yu et al., 2011), hence we predicted that Chd7 deficiency will predispose embryos to cerebellar vermis defects. Cerebellar size was normal in Chd7+/− and Fgf8+/− animals compared to wildtype littermates (Figure 2A–C), consistent with the observation that FGF signalling was not substantially reduced in these mutants (Figure 1H). To accurately compare the sizes of the cerebellar regions between mice, the volumes of cerebellar hemispheres, paravermis and vermis were calculated from surface area measurements taken from serial sections through postnatal day (P)21 cerebella. This analysis confirmed that cerebellar size was not significantly altered in Chd7+/− or Fgf8+/− mice (Figure 2E). Furthermore, cerebellar foliation in the vermis and hemispheres appeared normal in the mutants (Figure 2A’–C’,A”–C”). As Chd7−/− embryos die by E11.5, cerebellar development could not be analysed in these mutants. However, Chd7+/−;Fgf8+/− animals survive and an analysis of cerebellar size revealed a significant reduction in size owing to vermis aplasia (Figure 2D,D’,E). The cerebellar hemispheres were of normal size (Figure 2E) and had normal foliation compared to the controls (Figure 2D”). Cerebellar vermis aplasia in Chd7+/−;Fgf8+/− animals was already present at birth, confirming that defects arose during embryonic development (Figure 2F–I,F’–I’, red asterisk). We also noted that the posterior midbrain (inferior colliculus), another region that is particularly sensitive to FGF signalling levels, was abnormal in Chd7+/−;Fgf8+/− mutants (Figure 2I’, black asterisk). These observations provided functional evidence for a synergistic Chd7-Fgf8 interaction and indicated that the potential phenotypic consequences of diminished Fgf8 expression in Chd7+/− embryos could be revealed by Fgf8 heterozygosity.

Figure 2.
Download figureOpen in new tabDownload powerpointFigure 2. Chd7 and Fgf8 loss-of-function alleles interact to cause cerebellar vermis aplasia in the mouse.

(AD) Wholemount views of the mouse cerebellum at P21. The cerebellar vermis is indicated by a double-headed arrow. Chd7+/− animals have normal cerebella, indistinguishable from wildtype and Fgf8+/− control littermates. Chd7+/−;Fgf8+/− animals exhibit vermis aplasia (asterisk in D). Scale bar = 5 mm. (A’-D’) Cresyl violet-stained sagittal sections through the cerebellar vermis. Note the absence of cerebellar vermis tissue in Chd7+/−;Fgf8+/− embryos (D’). (A”D”) Sagittal sections through cerebellar hemispheres. (E) Measurements of cerebellar vermis, paravermis and hemisphere sizes in brains from the indicated genotypes. The data represents the mean of three samples with error bars indicating SEM. **p<0.001. (FI) Wholemount views of cerebella at birth (P0), with vermis indicated by arrows. (F’I’) Sagittal sections through P0 brains with inferior colliculus (IC) and cerebellum (Cb) indicated. Note the loss of cerebellar vermis (red asterisk) and abnormal IC (black asterisk) in Chd7+/−;Fgf8+/− animals (I’). Scale bar = 1 mm.

DOI: http://dx.doi.org/10.7554/eLife.01305.004

Deregulated homeobox gene expression and altered r1 identity in the absence of CHD7

The Chd7 gene encodes a SNF2H-like chromatin remodelling factor that is characterised by the presence of tandem chromodomains in its N-terminal region. Genome-wide chromatin immunoprecipitation studies in cell lines have shown that CHD7 is recruited to distal gene regulatory elements, presumably through interactions between CHD7 chromodomains and methylated lysine 4 residues in histone 3 (H3K4me), present at regulatory elements (Schnetz et al., 2009, 2010; Engelen et al., 2011). The Drosophila homologue of the CHD7 subfamily, kismet, was identified as a Trithorax gene and kismet mutants have reduced expression of homeotic genes and consequent transformations of body segments to more anterior structures (Daubresse et al., 1999). We therefore asked whether CHD7 has a role in maintaining the expression of homeobox genes that impart regional identity in the developing neural tube. The homeobox genes Otx2 and Gbx2 influence anterior and posterior identity in the developing embryo, respectively, position the IsO and regulate the levels of Fgf8 expression (Broccoli et al., 1999; Hidalgo-Sanchez et al., 1999; Millet et al., 1999; Joyner et al., 2000; Heimbucher et al., 2007). The analysis of Chd7−/− mouse embryos at E8.25 (4ss), shortly after the initiation of Fgf8 expression in the mes/r1 region revealed Otx2 upregulation and posterior expansion of its expression (Figure 3A,B, arrow indicating expanded expression). To investigate how the altered Otx2 expression domain related spatially to other hindbrain regions, we combined Otx2 in situ hybridisation with markers to visualise r3+r5 (Krox20) and r2 (Hoxa2) in the same embryo. Although Krox20 expression is reduced in Chd7 mutant embryos (Alavizadeh et al., 2001), r3 was still clearly marked, confirming the expansion of Otx2 expression towards r3 (Figure 3C,D). Combined Otx2/Hoxa2 in situ hybridisation experiments suggested that the expansion of Otx2 expression included most of r1, as indicated by the absence of the Otx2/Hoxa2-negative r1 in Chd7−/− embryos (Figure 3E,F).

Figure 3.
Download figureOpen in new tabDownload powerpointFigure 3. Chd7 loss results in Otx2 de-repression, loss of rhombomere 1 identity and reduced Fgf8 expression.

(A and B) In situ hybridisation for Otx2 in 4 somite stage (ss) embryos. Note the posterior expansion of Otx2 expression in the mutant embryo (arrow in B). (C and D) In situ hybridisation for Otx2 and Krox20 to mark the forebrain/mesencephalon and rhombomeres 3 and 5 (r3 and r5), respectively in 6 ss embryos. Note the posterior expansion of Otx2 (arrow) towards r3. (E and F) In situ hybridisation for Otx2 and Hoxa2, to mark the forebrain/mesencephalon and r2, respectively in 6 ss embryos. Note the posterior expansion of Otx2 (arrow) and apparent loss of the Otx2-Hoxa2-negative r1 in the Chd7−/− embryo. (G and H) Fgf8 in situ hybridisation on 6 ss embryos. Note the initiation of Fgf8 expression at the correct position in the mutant (H), despite posteriorised Otx2 expression. (I and J) Side-by-side comparison of Fgf8 and Otx2/Hoxa2 expression in 6 ss Chd7+/+ and Chd7−/− embryos. Note the posterior expansion of Otx2 expression (white arrow) and downregulated Fgf8 expression in the Chd7−/− embryos, compared to wildtype controls. Also note that Fgf8 expression is initiated at the correct position in the Chd7−/− embryo, with no evidence of a repositioning of the IsO in response to posterior expansion of Otx2 at this stage of development. (K and L) In situ hybridisation for Gbx2 suggesting the loss of r1 identity by E9. (M) Summary of regulatory interactions at the IsO in Chd7+/+ vs Chd7−/− embryos. The loss of Otx2 repression and Gbx2 maintenance by CHD7 are predicted to result in reduced Fgf8 expression in Chd7-deficient embryos. mes = mesencephalon, r1 = rhombomere 1, r2 = rhombomere 2, IsO = isthmus organiser.

DOI: http://dx.doi.org/10.7554/eLife.01305.005

We further confirmed that the posterior expansion of Otx2 expression in these early Chd7−/− embryos was associated with reduced Fgf8 expression (Figure 3G,H), in agreement with previously reported repression of Fgf8 expression by OTX2 (Acampora et al., 2001; Heimbucher et al., 2007). A side-by-side comparison of stage-matched embryos indicated that Fgf8 expression was initiated at the correct position in Chd7−/− embryos (Figure 3I,J). This observation showed that the posterior expansion of Otx2 expression was not associated with a re-positioning of the IsO and indicated that Otx2 was mis-expressed in the anterior hindbrain of Chd7−/− embryos. Therefore, we asked whether the abnormal expansion of Otx2 expression into the hindbrain just posterior to the IsO affected the identity of r1. Indeed, expression of the homeobox gene Gbx2, a marker of r1, was downregulated in Chd7−/− embryos (Figure 3K,L). These findings are consistent with the known regulatory interactions between Otx2, Gbx2 and Fgf8 (Figure 3M) (Broccoli et al., 1999; Millet et al., 1999). We conclude that CHD7 functions as a key regulator of homeobox gene expression in the early neural tube and that the loss of Chd7 results in the altered expression of Otx2 and Gbx2, and the concomitant transformation of r1 into a more anterior identity. Interestingly, the effect of Chd7 mutation on Otx2 expression appears to be highly context-dependent as Otx2 is reported to be downregulated in the otic and olfactory regions of Chd7-deficient embryos (Hurd et al., 2010; Layman et al., 2011).

CHD7 is associated with Otx2 and Gbx2 regulatory elements

The data presented thus far indicated that CHD7 is required for normal Otx2 and Gbx2 gene expression. We therefore sought evidence for CHD7 recruitment to Otx2 and Gbx2 regulatory regions. CHD7-associated chromatin was isolated from the mes/r1 region of E9.5 embryos by chromatin immunoprecipitation (ChIP), and genomic DNA fragments (indicated as #1–#10 in Figure 4A) quantified by qPCR. Specific CHD7 binding was observed at three Otx2 enhancer elements identified by Kurokawa et al. (Kurokawa et al., 2004a, 2004b). The FM1 enhancer, located ∼71–73 kb upstream (#8 in Figure 4A), and the FM2 enhancer (#1 in Figure 4A), located ∼118 kb downstream of Otx2 are by themselves sufficient to direct gene expression to the forebrain and midbrain after E9, and deletion of both enhancers together results in a smaller rostral brain and expanded r1 (Sakurai et al., 2010). DNA fragments within these Otx2 enhancers (#1, #8) were specifically enriched by CHD7 ChIP (Figure 4A). In addition, CHD7 was also present at the AN enhancer (#9 and #10 in Figure 4A) that can direct gene expression to the epiblast and anterior neuroectoderm prior to E9.0 (Kurokawa et al., 2004b), consistent with the observation that Otx2 expression was altered in E7.5 embryos (data not shown). We also detected CHD7 association with regions downstream of Otx2 (#3), and the promotor regions for Otx2.1 (#6) and Otx2.2 (#7) transcripts. No specific enrichment was detected at two negative control regions (#2 and #4). These data suggested that CHD7 is recruited to several key Otx2 regulatory elements in the embryonic mes/r1 region.

Figure 4.
Download figureOpen in new tabDownload powerpointFigure 4. Association of CHD7 with Otx2 and Gbx2 regulatory regions in the mes/r1 region.

(A) Genomic map of the mouse Otx2 locus. The transcriptional start sites of Otx2.1 and Otx2.2 transcripts are indicated by arrows and exons by tan-coloured boxes. Positions on chromosome 14 indicated above the diagram are according to the mm9 genome assembly and numbers below the horizontal lines indicate approximate positions relative to the Otx2.2 transcriptional start site. Known Otx2 enhancer regions FM1, FM2 and AN are indicated by blue boxes (Kurokawa et al., 2004a, 2004b). The location of DNA fragments amplified by qPCR after ChIP are indicated by rectangular boxes numbered #1–#10. Open boxes indicate negative control regions. ChIP-qPCR data are presented in a graph, with % of input DNA on the Y-axis and amplified region on the X-axis. Results from ChIP reactions using a CHD7-specific antiserum are in magenta and control Ig in turquoise. Error bars indicate standard deviation from reactions performed in triplicate. (B) Genomic map of the mouse Gbx2 locus with the transcriptional start site (TSS) indicated by an arrow and exons by tan-coloured boxes. Positions on chromosome 1 indicated above the diagram are according to the mm9 genome assembly and numbers below the horizontal lines indicate approximate positions relative to the TSS. The location of DNA fragments amplified by qPCR after ChIP are indicated by rectangular boxes numbered #1–#6. Open boxes indicate negative control regions. ChIP-qPCR data are presented in a graph, with % of input DNA on the Y-axis and amplified region on the X-axis. Results from ChIP reactions using a CHD7-specific antiserum are in magenta and control Ig in turquoise. Error bars indicate standard deviation from reactions performed in triplicate.

DOI: http://dx.doi.org/10.7554/eLife.01305.006

A regulatory region 6 kb upstream of zebrafish Gbx2 capable of driving gene expression in r1, has been described by Islam et al. (2006). ChIP-qPCR experiments identified substantial CHD7 recruitment to a region 5–6.25 kb upstream (#3, #4 and #5 in Figure 4B) as well as 3.7 kb upstream of Gbx2 (#1) in mes/r1 tissue. These observations suggested that CHD7 might regulate Gbx2 expression in r1 by interacting with Gbx2 regulatory elements. However, further experiments will be required to test whether these regions do indeed control Gbx2 expression in mouse r1.

Taken together, our observations support the supposition that homeobox genes represent key CHD7 targets. The mechanisms controlling CHD7 recruitment to regulatory regions and the action whereby CHD7 might affect gene expression in the embryo remain to be elucidated.

Cerebellar defects of CHARGE syndrome patients

Cerebellar defects have been reported in pre-term CHARGE fetuses (Becker et al., 2001; Sanlaville et al., 2006; Legendre et al., 2012). To determine whether cerebellar defects are a common post-natal feature of CHARGE syndrome, we systematically examined cerebellar structure in a cohort of 20 patients with CHARGE syndrome and mutations in the CHD7 gene. MRI scans revealed cerebellar defects in 55% (11/20) of these patients (Figure 5; Table 1). Patients exhibited cerebellar vermis hypoplasia, varying from slight to pronounced hypoplasia (35%, 7/20, Figure 5B,C) and an anticlockwise rotated vermis (35%, 7/20, Figure 5B,C’). As a consequence of these abnormalities, fluid-filled spaces surrounding the cerebellum appeared larger. Examples of large foramen of Magendi and fourth ventricle (50%, 10/20) and large subcerebellar cistern (25%, 4/20) are indicated in Figure 5B–D. Thus, cerebellar defects in CHARGE syndrome have some clinical similarities to Dandy-Walker malformations (vermis hypoplasia and anticlockwise rotated vermis), without the overt posterior fossa enlargement typical of Dandy-Walker malformation (Doherty et al., 2013). Two patients with vermis hypoplasia exhibited broad gait or ataxia, consistent with defects that disrupt cerebellar function (Table 1). Furthermore, 25% (5/20) of the patients had foliation abnormalities (Figure 5D,D’, Table 1), implying additional roles for CHD7 during the process of foliation. We conclude that a substantial proportion of patients with CHARGE syndrome present with cerebellar vermis hypoplasia. The incomplete penetrance of cerebellar vermis defects in patients with CHD7 mutations is consistent with our studies in the mouse, which suggests that mutations in FGF pathway genes are likely to substantially modify the severity of cerebellar defects in CHARGE syndrome.

Figure 5.
Download figureOpen in new tabDownload powerpointFigure 5. Representative sagittal MRI scans of CHARGE syndrome patients.

(A) Sagittal T1 scan of patient #18 showing a normal vermis with a normal position, foramen of Magendi (asterisk) and subcerebellar cistern (SC). The orientation of the cerebellum relative to the brainstem is indicated by two parallel white lines. (B) Sagittal T1 scan of patient #5 showing pronounced vermis hypoplasia with an anticlockwise rotated axis relative to the axis of the brainstem (arrow), and ensuing large foramen of Magendi (asterisk) and subcerebellar cistern (SC). Cerebellar hemispheres are normal (not shown). (C and C’) Illustrative sagittal T1 MRI images of patient #3 showing a slightly hypoplastic vermis. The white lines and arrow in C’ indicate the anticlockwise-rotated axis of the vermis compared to the axis of the brainstem, with ensuing large foramen of Magendi (asterisk) and subcerebellar cistern (SC) indicated in C. (D) Transverse Inversion Recovery MRI image of patient #10 showing abnormal foliation in the caudal cerebellar hemispheres extending into the cerebellar tonsils (arrow). Also note a wide foramen of Magendi (asterisk). (D’) Transverse T2 MRI image of patient #11, with abnormal foliation in the anterior vermis indicated by an arrow. (E) Transverse Inversion Recovery image and (E’) T2 MRI image of a control patient with normal cerebellum.

DOI: http://dx.doi.org/10.7554/eLife.01305.007

View this table:
Table 1.

Cerebellar findings on MRI scans

DOI: http://dx.doi.org/10.7554/eLife.01305.008

In summary, this study identifies the chromatin-remodelling factor CHD7 as a key upstream regulator of homeobox gene expression and positional identity in the early neural tube and demonstrates a connection between CHD7 haplo-insufficiency, reduced FGF signalling and cerebellar defects in a human syndrome. We propose that CHD7 remodels chromatin at multiple Otx2 and Gbx2 regulatory elements, thereby modifying higher order chromatin architecture and interactions with tissue-specific transcription factors at these loci. Although we cannot completely rule out the possibility that CHD7 also directly fine-tunes Fgf8 expression in addition to affecting Otx2 and Gbx2 expression, the finding that Fgf8 expression is not substantially changed in the pharyngeal region of Chd7−/− embryos (compare e.g., Figure 3G with H), suggest that such effects will have to be mediated by CHD7 recruitment to tissue-specific Fgf8 regulatory elements.

Our findings predict that mutations and epigenetic alterations of OTX2 and GBX2 regulatory regions are likely to contribute to cerebellar hypoplasia in humans and that OTX2, GBX2 and FGF8 deregulation might underlie other developmental defects associated with CHARGE syndrome.

Materials and methods

Animals

The Chd7XK403 and Fgf8lacZ/+ loss-of-function alleles were maintained on C57BL/6J and C57BL/6J × DBA/2J F1 backgrounds for these studies (Ilagan et al., 2006; Randall et al., 2009). Tail DNA preparations were genotyped by PCR as described in the original publications. All animal procedures were approved by the UK Home Office.

Histology and volumetric analysis

Brains were dissected in ice-cold PBS, fixed in 4% paraformaldehyde (PFA) overnight at 4°C, before dehydration and embedding in paraffin wax. Volumetric measurements were carried out on P0 and P21 cerebella. Serial, sagittal 10 μm sections of the cerebellum were dried overnight at 42°C, rehydrated and stained with 0.1% cresyl violet. Images of stained sections were taken and the cerebellar surface area on each section traced and measured by ImageJ. The total volume of each cerebellar region was calculated by multiplying the total surface area of all sections from the same region by the thickness of the sections. Vermis sections were selected as the most medial sections with clearly visible 10 lobules; paravermis sections were adjacent to the vermis sections, with diminishing lobules VIII, IX and X; sections lateral to paravermis were hemisphere sections.

Whole-mount in situ hybridisation

Noon on the day a vaginal plug was observed was defined as embryonic day (E)0.5. Somite-stage embryos were staged more accurately by counting the number of somite pairs. After dissection in ice-cold PBS, embryos were fixed overnight in 4% PFA at 4°C, gradually dehydrated in a methanol series and in situ hybridisation carried out using standard procedures (Wilkinson et al., 1989b). Digoxigenin-labelled antisense probes for Etv5 (Hippenmeyer et al., 2002), Fgf8 (Crossley and Martin, 1995), Gbx2 (Wassarman et al., 1997), Hoxa2 (Wilkinson et al., 1989a) and Otx2 (Simeone et al., 1993) were prepared using previously published constructs.

Quantitative RT-PCR analyses

Total RNA was extracted from the mes/r1 region of at least three E9.5 embryos of each genotype using Trizol (Invitrogen, UK) with the addition of 20 µg Ultrapure Glycogen (Life Technologies, UK). A total of 200 ng of RNA was used for first-strand DNA synthesis with the nanoScript Precision RT kit (PrimerDesign Ltd., UK) using random hexamer primers. cDNA synthesis reactions without reverse transcriptase enzyme (no RT) were used as controls for quantitative RT-PCR. Quantitative RT-PCR was performed on a Rotor-Gene Q (Qiagen) using Precision qPCR MasterMix kit with SYBR green (Primerdesign Ltd., UK). All reactions were performed in triplicate. Cq threshold values were determined manually and all were at least 5 Cq values below no RT controls. The Cq values for each sample was normalised to the internal control gene Ywhaz (primers provided by Primerdesign) to give the ΔCq value. ΔΔCq values were calculated relative to wildtype samples. The primer sequences used were: Fgf8: forward 5′-AGGTCTCTACATCTGCATGAAC-3′, reverse 5′-TGTTCTCCAGCACGATCTCT-3′; Etv5: forward 5′-GCAGTTTGTCCCAGATTTTCA-3′, reverse 5′-GCAGCTCCCGTTTGATCTT-3′.

Chromatin immunoprecipitation (ChIP)-qPCR

The embryonic mes/r1 region was dissected from E9.5 CD1 embryos, disrupted by trituration with a 23 G and 25 G needle, fixed for 10 min with 4% PFA, snap-frozen and stored at −80°C until use. After cell lysis and isolation of nuclei, samples were sonicated in a Bioruptor UCD-300 in 10 mM TRIS pH8, 1 mM EDTA, 0.5 mM EGTA, 0.5% N-lauroylsarcosine to 200–500 bp fragment size. Chromatin was immunoprecipiated with antiserum to CHD7 (ab31824, Abcam, UK) and control Ig (Abcam, UK). Complexes were captured with Protein G Dynabeads, washed with modified RIPA buffer (50 mM HEPES pH7.5, 1 mM EDTA, 0.3% Sodium deoxycholate, 1% NP40, 250 mM LiCl), eluted in 50 mM TRIS pH8, 10 mM EDTA, 1% SDS, cross-links reversed by overnight incubation at 65°C and DNA precipitated after phenol-chloroform extraction. Unique DNA fragments were amplified and quantified by qPCR using the primers in Tables 2 and 3. Data were quantified relative to input DNA (% of input).

View this table:
Table 2.

Otx2 qPCR primers

DOI: http://dx.doi.org/10.7554/eLife.01305.009

View this table:
Table 3.

Gbx2 qPCR primers

DOI: http://dx.doi.org/10.7554/eLife.01305.010

Patients

All patients included in this study are known at the Dutch expert clinic for CHARGE syndrome located at the University Medical Center Groningen (coordinated by CvRA). All patients had a pathogenic mutation in CHD7 (Table 1, see also www.CHD7.org). Patients were all evaluated in person by CvRA. Patients and/or parents gave written consent for the collection and analysis of detailed phenotypic information according to national ethical guidelines. Phenotypic information collected also included radiological images. All information is stored in a secure database under a unique patient identification number.

MRI scans

The MRI scans were made at different hospitals. A total of 23 MRI scans could be collected. Only MRI scans that allowed a reliable interpretation of the cerebellum, that is the presence of sagittal and axial images of the cerebellum, were included in this study (n = 20). All cerebellar images were evaluated on visual basis by an experienced neuroradiologist (LCM). MRI images of CHARGE patients were compared with images of age-matched controls. All observations were recorded by MTYW.

References

Acknowledgements

We thank the individuals with CHARGE syndrome and their families for participating in our research. Lies Hoefsloot supervised the diagnostic CHD7 sequencing of the CHARGE patients. Jorieke van Kammen-Bergman assisted in the collection of cerebral MRI scans. Samantha Martin provided technical assistance and mouse husbandry. We thank Wee-Wei Tee and Shuzo Kaneko for advice on ChIP experiments, Gail Martin, Alex Joyner and John Rubenstein for mouse lines and in situ probes and members of the Basson laboratory and Anthony Graham, Clemens Kiecker and Mohi Ahmed for comments on the manuscript. This work is supported by grants from the Wellcome Trust (091475) and the Medical Research Council (MR/K022377/1) to MAB, Fund Nuts-Ohra (1202–023) to MTYW, and BHF grants PG/12/44/29658 and RG/15/13/28570 to PJS.

Decision letter

Robb Krumlauf, Reviewing editor, Stowers Institute for Medical Research, United States

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see review process). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled “Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome” for consideration at eLife. Your article has been favorably evaluated by a Senior editor and 4 reviewers, one of whom is a member of our Board of Reviewing Editors.

The following individuals responsible for the peer review of your submission have agreed to reveal their identity: Robb Krumlauf (Reviewing editor); Kathleen Millen and Mark Lewandowski (peer reviewers).

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

There was a uniform opinion among the reviewers that this was an interesting paper thath would be suitable for publication in eLife following revisions to address several concerns.

1) This study formally adds cerebellar malformation to the features of CHARGE, demonstrating that isthmic disruption can cause human cerebellar malformations as has long been demonstrated in mice and other models. However, the authors oversell the connection by claiming (in the Abstract and start of the section on cerebellar defects) that their mouse observations “led us to search for cerebellar defects...”. Rather, several previous clinical reports clearly described the occurrence of vermis deficiency as a non-random association with CHARGE, although the authors' series appears the largest in which an MRI study has been conducted.

2) An additional major concern is with the phenotypic features of the MRI data in Table 1. As Barkovich and others have pointed out, Dandy-Walker Variant is not acceptable terminology (see more recent references Barkovivh 2009; Aldinger 2009). Dandy-Walker malformation is a combination of cerebellar hypoplasia and posterior fossa enlargement. These MRI scans show cerebellar vermis hypoplasia. There is not clear evidence of an enlarged posterior fossa.

3) In the cases shown, the enlarged fourth ventricle is simply filling a normal-sized or perhaps even small posterior fossa. It is an illusion that the cisterna is enlarged. The cerebellum is small, so the space looks large. Other features are noted, but are not visible in the panels presented – in particular the large foramen of Magendi and indented dorsal pons, abnormal foliation in 2 cases. These issues in establishing the connections of cerebellar defects to CHARGE and the interpretation need to be properly dealt with in the text.

4) An important aspect of the work relates to the conclusion that Chd7 directs binds regulatory regions of the Otx2 locus. However there are concerns about the technical aspects of this data. The ChIP-PCR study of Otx2 in Figure 4 is weak and heavily influenced by a genome-wide ChIP-seq study of murine ES cells described by Schnetz et al. The authors (1) did not provide primer sequences for the regions of Otx2 analysed (which were chosen from the Schnetz work) and more importantly (2) did not provide any negative control data, for example comparing with other regions of the Otx2 gene sequence. Although there are some suggestive correlations with other epigenetic marks, there are too few analyses to contextualise the signal they obtained and therefore to interpret it, as they do, as “suggesting a role for CHD7 in directly regulating Otx2 gene expression through interacting with these elements”. This part of the work would ideally need to be strengthened by conducting a complete PCR-based survey of the Otx2 gene. Even then, since CHD7 may not bind DNA directly, the conclusions are indirect without a lot more information on co-binding factors. Since this is likely to be beyond the scope of this work, the authors should revise the text to interpret the direct action of Chd7 on Otx2 more circumspectly, taking into consideration these potential caveats.

5) Did they consider undertaking a similar study of Gbx2?

6) The data in Figure 3A,B do not clearly show differences in Gbx2 and Otx2 expression. While it is clear at the later stages the data at E7.5 are not very compelling and add little to the story. They should either be removed, or to clarify the embryonic data at E7.5 the authors should repeat the Otx2/Gbx2 analysis with embryos that are more closely stage-matched. In particular, the Otx2-stained normal embryo is clearly older than the Chd7 mutant.

7) The posterior expansion of Otx2 is an important observation. Figure 3D shows a 6ss embryo doubly stained for both Otx2 and Hoxa2. The expanded region of label is interpreted to be due to caudally expanded Otx2 expression, but it could also be due to Hoxa2 expression rostrally expanded from r2. This could be resolved with two color “in situs”. However, another solution is to stain solely for Otx2 and place a photo of such a sample as an insert in 2D. Alternatively a more compelling way to illustrate the shifts and a potential transformation would be to employ Krox20. It is expressed in r3 and r5. This would indicate that the changes were restricted to r1 and not a truncation of the anterior hindbrain. This general issue needs to be addressed in one of the ways suggested above.

DOI: http://dx.doi.org/10.7554/eLife.01305.011

Author response